NCT00168714View on ClinicalTrials.gov

Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)

CompletedOBSERVATIONAL
Enrollment

329

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Prenatal Exposure Delayed EffectsMultiple SclerosisPregnancy
Interventions
DRUG

BG9418 (interferon beta-1a)

Exposure to Avonex during pregnancy

Trial Locations (1)

28405

Kendle, Wilmington

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY